December 15th, 2015

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

China Biologic Produ (NQ: CBPO )

118.45 USD -0.03 (-0.03%)
Streaming Delayed Price Updated: 1:43 PM EST, Jan 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about China Biologic Produ

China Biologic Reports Financial Results for the Third Quarter of 2020
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited... 
From PR Newswire
China Biologic Enters into Definitive Merger Agreement for Going Private Transaction
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that it has entered... 
From PR Newswire
China Biologic Products to Report Third Quarter 2020 Financial Results
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company... 
From PR Newswire
Bullish Stocks Trading Near Their All-time high: $LSCC $PSTG $CBPO
Tags The Market Signal
From The Market Signal
China Biologic Reports Financial Results for the Second Quarter of 2020
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited... 
From PR Newswire
China Biologic Products to Report Second Quarter 2020 Financial Results
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company... 
From PR Newswire
China Biologic Provides Additional Comments on the Xinjiang Deyuan and Shuanglin Transaction
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today declared that the Company... 
From PR Newswire
China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today declared that Xinjiang Deyuan... 
From PR Newswire
China Biologic Reports Financial Results for the First Quarter of 2020
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited... 
From PR Newswire
China Biologic Products to Report First Quarter 2020 Financial Results
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company... 
From PR Newswire
Thinking about trading options or stock in Boeing, China Biologic Products, FedEx, Intel, or JPMorgan?
InvestorsObserver issues critical PriceWatch Alerts for BA, CBPO, FDX, INTC, and JPM. 
From PR Newswire
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2019
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its financial... 
From PR Newswire
China Biologic Products to Report Fourth Quarter and Fiscal Year 2019 Financial Results
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company... 
From PR Newswire
Centurium Capital and Certain Other Investors File a Transaction Statement on Schedule 13E-3 with the U. S. Securities and Exchange Commission
Centurium Capital, a leading private equity firm in China, today announced that several of its affiliate entities, namely Beachhead Holdings Limited ("Beachhead"), Double Double Holdings Limited... 
From PR Newswire
China Biologic Reports Financial Results for the Third Quarter of 2019
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited... 
From PR Newswire
China Biologic Products to Report Third Quarter 2019 Financial Results
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company... 
From PR Newswire
China Biologic Special Committee Retains Financial Advisor and Legal Counsel
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the special... 
From PR Newswire
China Biologic Forms Special Committee to Review "Going Private" Proposal
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that its board of... 
From PR Newswire
China Biologic Announces Receipt of Preliminary Non-Binding "Going Private" Proposal
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that its board of... 
From PR Newswire
China Biologic Reports Financial Results for the Second Quarter of 2019
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited... 
From PR Newswire
China Biologic Products to Report Second Quarter 2019 Financial Results
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company... 
From PR Newswire
China Biologic Reports Financial Results for the First Quarter of 2019
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited... 
From PR Newswire
China Biologic Products to Report First Quarter 2019 Financial Results
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company... 
From PR Newswire
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its financial... 
From PR Newswire
China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company... 
From PR Newswire
China Biologic Reiterates Full Year 2018 Financial Forecast
China Biologic Products Holdings, Inc. (NASDAQ: CBPO)("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today reiterated its previously... 
From PR Newswire
David Gao Issues Statement Following Decision by the Grand Court of the Cayman Islands
Mr. David (Xiaoying) Gao, a shareholder of China Biologic Products Holdings, Inc. (“China Biologic” or the “Company”) (NASDAQ: CBPO), today issued the following statement on the Grand Court of the... 
From Business Wire News Releases
China Biologic Announces Dismissal of Lawsuit Filed in Cayman Islands by Former Chairman
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Grand... 
From PR Newswire
China Biologic Reports Financial Results for the Third Quarter of 2018
China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited... 
From PR Newswire
China Biologic Products to Report Third Quarter 2018 Financial Results
China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company... 
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

3257 Dunmore Rd SE
Medicine Hat, AB T1B 3R2

[P] 403.527.1101
[F] 403.528.5696

Print Advertising: 403.528.5650
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2015 The Medicine Hat News, A Division of Continental Newspapers Canada Ltd.